J0593, Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug
HCPCS/CPT
Prior Authorization
Prior Auth Required
Conditional coverage; review criteria to confirm PA need (medium confidence)
Medicare Pricing
Work RVU
0.00
Facility
N/A
Non-Facility
N/A
4 Active Policies
BCBSLA-00654-94D2E64653, 00654 lanadelumab-flyo (Takhzyro)
LA
POINT32HEALTH-MDMNG-13936, Takhzyro (lanadelumab-flyo)
MULTI
BCBSNJ-DRUGS-063-5CE01BD5D5, Drug Therapy for Hereditary Angioedema [Cinryze, Berinert, Haegarda (Human C1 Inhibitor), Kalbitor (Ecallantide), Firazyr (Icatibant), Ruconest (C1 Esterase Inhibitor [Recombinant]), Takhzyro (lanadelumab-flyo)]
NJ
HEALTHNET_OR-HNOR-LANADELUMAB-FYLO-TAKHZYRO-CP-PHAR-396-EBD35BF869
Related Codes
Have a follow-up question?
Ask Verity about documentation requirements, denial risks, or coverage in your state.